Rapid risk assessment: Multi-country outbreak of hepatitis A virus genotype IA infections affecting EU countries in 2018
After the EPIS FWD notification of a cluster of hepatitis A cases infected with two distinct strains in several EU/EEA countries, this risk assessment presents the early findings of this multi-country hepatitis A outbreak and sets out initial options for response.
The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: A systematic review
Greenaway, C., Pareek, M., Abou, C.-N.C., Walji, M., Makarenko, I., Alabdulkarim, B., Hogan, C., McConnell, T., Scarfo, B., Christensen, R., Tran, A., Rowbotham, N., Noori, T., van der Werf, M.J., Pottie, K., Matteelli, A., Zenner, D., Morton, R.L.
EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods
In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.